WuXi Biologics (Cayman) Inc banner

WuXi Biologics (Cayman) Inc
OTC:WXIBF

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
OTC:WXIBF
Watchlist
Price: 4.4 USD Market Closed
Market Cap: $19.1B

Wall St Price Targets

WXIBF Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WXIBF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WXIBF is 6.09 USD with a low forecast of 4.07 USD and a high forecast of 10.97 USD.

Lowest Forecast
Price Target
4.07 USD
7% Downside
Average Forecast
Price Target
6.09 USD
38% Upside
Highest Forecast
Price Target
10.97 USD
149% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
TES
Tesmec SpA
-26% Downside

Revenue
Forecast

44% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
44% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.

Gross Profit
Forecast

49% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
49% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for WuXi Biologics (Cayman) Inc

Operating Income
Forecast

61% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
61% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 10 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is 15%.

Pre-Tax Income
Forecast

60% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
60% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for WuXi Biologics (Cayman) Inc

Net Income
Forecast

60% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
60% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is WXIBF's stock price target?
Price Target
6.09 USD

According to Wall Street analysts, the average 1-year price target for WXIBF is 6.09 USD with a low forecast of 4.07 USD and a high forecast of 10.97 USD.

What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%

Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.

What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%

Over the last 10 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is 15%.

What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
12%

Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett